These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15176317)

  • 1. Development of a recombinant FimCH vaccine for urinary tract infections.
    Langermann S; Ballou WR
    Adv Exp Med Biol; 2003; 539(Pt B):635-48. PubMed ID: 15176317
    [No Abstract]   [Full Text] [Related]  

  • 2. Adhesion and invasion of Escherichia coli. Studies on function and regulation.
    Oelschlaeger TA; Morschhäuser J; Meier C; Schipper C; Hacker J
    Adv Exp Med Biol; 1996; 408():57-62. PubMed ID: 8895777
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
    Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
    Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections.
    Savar NS; Jahanian-Najafabadi A; Mahdavi M; Shokrgozar MA; Jafari A; Bouzari S
    J Biotechnol; 2014 Apr; 175():31-7. PubMed ID: 24530504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response.
    Bergsten G; Samuelsson M; Wullt B; Leijonhufvud I; Fischer H; Svanborg C
    J Infect Dis; 2004 May; 189(9):1734-42. PubMed ID: 15116313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections.
    Langermann S; Ballou WR
    J Infect Dis; 2001 Mar; 183 Suppl 1():S84-6. PubMed ID: 11171023
    [No Abstract]   [Full Text] [Related]  

  • 7. New vaccines may ward off urinary tract infections.
    Service RF
    Science; 1997 Apr; 276(5312):533. PubMed ID: 9148412
    [No Abstract]   [Full Text] [Related]  

  • 8. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and development of FimH lectin domain for rising immune response after injection by uropathogenic E. coli.
    Zandi M; Fallah Mehrabadi J; Mahdavi M; Irani S
    Hum Antibodies; 2020; 28(2):169-178. PubMed ID: 32116244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fimch antiserum inhibits the adherence of Escherichia coli to cells collected by voided urine specimens of diabetic women.
    Meiland R; Geerlings SE; Langermann S; Brouwer EC; Coenjaerts FE; Hoepelman AI
    J Urol; 2004 Apr; 171(4):1589-93. PubMed ID: 15017227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic
    Luna-Pineda VM; Reyes-Grajeda JP; Cruz-Córdova A; Saldaña-Ahuactzi Z; Ochoa SA; Maldonado-Bernal C; Cázares-Domínguez V; Moreno-Fierros L; Arellano-Galindo J; Hernández-Castro R; Xicohtencatl-Cortes J
    Front Cell Infect Microbiol; 2016; 6():135. PubMed ID: 27843814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
    Roberts JA; Kaack MB; Baskin G; Chapman MR; Hunstad DA; Pinkner JS; Hultgren SJ
    J Urol; 2004 Apr; 171(4):1682-5. PubMed ID: 15017266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    Thankavel K; Madison B; Ikeda T; Malaviya R; Shah AH; Arumugam PM; Abraham SN
    J Clin Invest; 1997 Sep; 100(5):1123-36. PubMed ID: 9276729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Candidate vaccine against urinary tract infections].
    Hoepelman IM; Meiland R; Langermann S
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1860-2. PubMed ID: 11593791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response against adhesins of enteroaggregative Escherichia coli immunized by three different vaccination strategies (DNA/DNA, Protein/Protein, and DNA/Protein) in mice.
    Bouzari S; Dashti A; Jafari A; Oloomi M
    Comp Immunol Microbiol Infect Dis; 2010 May; 33(3):215-25. PubMed ID: 19022502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis.
    Habibi M; Asadi Karam MR; Bouzari S
    APMIS; 2016 Jun; 124(6):444-52. PubMed ID: 26918627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular analysis of uropathogenic strains of Escherichia coli and the clinical course of urinary tract infection in children].
    Rytlewska M; Liberek A; Sikorska-Wisniewska G; Zalewska B; Kurlenda J; Korzon M
    Med Wieku Rozwoj; 2005; 9(4):727-39. PubMed ID: 16733281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of FaeG, the major subunit of K88 fimbriae, in transgenic tobacco plants and its immunogenicity in mice.
    Huang Y; Liang W; Pan A; Zhou Z; Huang C; Chen J; Zhang D
    Infect Immun; 2003 Sep; 71(9):5436-9. PubMed ID: 12933900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal immunization with a recombinant truncated FimH adhesin adjuvanted with CpG oligodeoxynucleotides protects mice against uropathogenic Escherichia coli challenge.
    Poggio TV; La Torre JL; Scodeller EA
    Can J Microbiol; 2006 Nov; 52(11):1093-102. PubMed ID: 17215901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-fimbriae in the presence of anti-PapA antibodies: new insight of antibodies action against pathogens.
    Mortezaei N; Singh B; Bullitt E; Uhlin BE; Andersson M
    Sci Rep; 2013 Dec; 3():3393. PubMed ID: 24292100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.